Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on June 12, 2025
Spring Bio Solution lance NCE Grid pour décoder les dépôts Para IV et les opportunités de premier déposant
GlobeNewswire
·
June 12, 2025
SOMERSET, New Jersey, 12 juin 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, l’un des leaders mondiaux de l’approvisionnement en comparateurs et en matériel pour essais cliniques, a lancé NCE Grid, une plateforme d’informations NCE-1 gratuite. Conçue pour …
Spring Bio Solution Meluncurkan NCE Grid untuk Mendekode Peluang Pengajuan Para IV dan First-to-File
GlobeNewswire
·
June 12, 2025
SOMERSET, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, pemimpin global dalam pengadaan obat pembanding dan perlengkapan uji klinis, telah meluncurkan NCE Grid, platform kecerdasan NCE-1 gratis pertama di dunia - yang dibuat untuk mendekode, …
スプリング・バイオ・ソリューション (Spring Bio Solution) 、パラグラフIV証明書を伴う申請 (Para IV Filing) およびファースト・トゥ・ファイル機会を解析するNCEグリッド (NCE Grid) を発表
GlobeNewswire
·
June 12, 2025
ニュージャージー州サマセット発, June 12, 2025 (GLOBE NEWSWIRE) -- コンパレータ調達および治験薬供給のグローバルリーダーであるスプリング・バイオ・ソリューションは、世界初の無料NCE-1インテリジェンス・プラットフォームであり、パラグラフIVおよびNCE-1の機会をリアルタイムで解析・集約・可視化することを目的として構築されたNCEグリッドを発表した。 これまで、NCE独占期間の満了およびパラグラフIV …
Spring Bio Solution, 패러그래프 IV 준비와 최초 출원 가능성 해석해주는 NCE Grid 플랫폼 선보여
GlobeNewswire
·
June 12, 2025
미국 뉴저지주 서머싯, June 12, 2025 (GLOBE NEWSWIRE) -- 대조약 공급 및 임상시험 용품 분야의 글로벌 선도 기업 Spring Bio Solution이 세계 최초로 무료 NCE-1 인텔리전스 플랫폼 NCE Grid를 선보였다. 이 플랫폼은 패러그래프 IV 준비와 NCE-1 가능성을 실시간으로 해석하고, 중앙화 및 시각화하기 위해 설계되었다. 지금까지 NCE 독점권 만료일 추적과 패러그래프 IV 증명서 제출은 중앙화된 솔루션이 없어 …
Spring Bio Solution Melancarkan NCE Grid untuk Menyahkod Pemfailan Para IV dan Peluang Pemfail Pertama
GlobeNewswire
·
June 12, 2025
SOMERSET, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, peneraju global dalam penyumberan komparator dan bekalan percubaan klinikal telah melancarkan NCE Grid, platform risikan NCE-1 percuma pertama di dunia—dibangunkan untuk menyahkod, …
Spring Bio Solution 推出 NCE Grid，用于分析 Para IV 申请和“首先申请”机会
GlobeNewswire
·
June 12, 2025
萨默塞特，新泽西州, June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution 是对照药采购和临床试验用品领域的全球领导者，近日推出了 NCE Grid，这是全球首个免费的 NCE-1（新化学实体批准日期满48个月后的第一天，通常被称为“首仿日”）情报平台，用于实时分析及实现 Para IV（第IV段声明专利挑战） 和 NCE-1 机会的集中化和可视化。 在这之前，追踪 NCE 独占期到期情况和 Para IV …
Spring Bio Solution เปิดตัว NCE Grid เพื่อถอดรหัสการยื่นเอกสาร Para IV และโอกาสในการยื่นคำขอครั้งแรก
GlobeNewswire
·
June 12, 2025
ซอเมอร์เซ็ต นิวเจอร์ซีย์, June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution ผู้นำระดับโลกในด้านการจัดหาตัวเปรียบเทียบและอุปกรณ์การทดลองทางคลินิก ได้เปิดตัว NCE Grid แพลตฟอร์มปัญญาประดิษฐ์ NCE-1 ฟรีแห่งแรกของโลกที่สร้างขึ้นเพื่อถอดรหัส การรวมข้อมูล …
Spring Bio Solution 推出 NCE Grid，用於分析 Para IV 申請和「首先申請」機會
GlobeNewswire
·
June 12, 2025
薩默塞特，新澤西州, June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution 是對照藥採購和臨床試驗用品領域的全球領導者，近日推出了 NCE Grid，這是全球首個免費的 NCE-1 情報平台，用於即時分析及實現 Para IV 和 NCE-1 機會的集中化和可視化。 到目前為止，追蹤 NCE 專有權到期情況和 Paragraph IV 申請一直是分散且繁瑣的人手程序，缺乏集中式解決方案。 …
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
GlobeNewswire
·
June 12, 2025
PRINCETON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced new preclinical data on the use of Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel) in a mouse …
Counslr Launches in Texas to Increase Access to Mental Health Support for Staff and Students
GlobeNewswire
·
June 12, 2025
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading B2B mental health and wellness platform, announced today that it has expanded its footprint into the State of Texas starting with a partnership with Colorado Independent School District (ISD) …
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire
·
June 12, 2025
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study results expanded upon top line data …
Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström…
GlobeNewswire
·
June 12, 2025
Complete response achieved in CLL; overall objective response rate of 80.9% in CLL patients and 84.2% in patients with WM Bexobrutideg was well tolerated with no new safety signals observed with longer duration on study or higher doses Data reinforces …
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
GlobeNewswire
·
June 12, 2025
EXTON, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the publication of pivotal clinical trial results in the American …
Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025
GlobeNewswire
·
June 12, 2025
– 26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population – – Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy- …
I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
June 12, 2025
ROCKVILLE, Md., June 12, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (“I-Mab” or the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that on …
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
GlobeNewswire
·
June 12, 2025
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT …
BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
GlobeNewswire
·
June 12, 2025
Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer wichtiger Meilenstein in der Umsetzung von BioNTechs Onkologie-Strategie Die Übernahme …
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
GlobeNewswire
·
June 12, 2025
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy Acquisition of CureVac will complement …
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewswire
·
June 12, 2025
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central …
MedRisk Welcomes Satish Narayanan as Chief Data Officer, Expanding Data and AI Capabilities
GlobeNewswire
·
June 12, 2025
KING OF PRUSSIA, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- MedRisk, a leading managed care organization focused on improving recovery and cost outcomes in casualty claims, announced today the appointment of Satish Narayanan as Chief Data Officer (“CDO”). In …